Vimta Labs Limited operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vimta Labs Limited with three other
miscellaneous service companies in Asia:
Japan Tissue Engineering Company Limited
sales of 2.14 billion Japanese Yen [US$19.11 million]
of which 96%
was Regenerative Medicine Products Business),
Trans Genic Inc
(2.30 billion Japanese Yen [US$20.61 million]
of which 50%
was CRO Business), and
PhoenixBio Co Ltd
based in Japan
(1.23 billion Japanese Yen [US$11.00 million]
During the year ended March of 2017, sales at
Vimta Labs Limited were 1.53 billion Indian Rupees (US$23.62 million).
increase of 23.0%
versus 2016, when the company's sales were 1.25 billion Indian Rupees.